Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Shimon

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Pituitary|November 18, 2000
Acromegaly with normal growth hormone levels: response to Sandostatin-LAR treatmentI Shimon, D Nass, M Hadani
Clinical Endocrinology|November 1, 1995
Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literatureI Shimon, A Kneller, D Olchovsky
Hormone Research|January 1, 1995
Home monitoring of 17 alpha-hydroxyprogesterone levels by filter paper blood spots in patients with 21-hydroxylase deficiencyI Shimon, I Kaiserman, J Sack
The Journal of Clinical Endocrinology and Metabolism|January 22, 1998
Human fetal pituitary expresses functional growth hormone-releasing peptide receptorsI Shimon, X Yan, S Melmed
Journal of Endocrinological Investigation|June 1, 1995
Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma)M Berezin, I Shimon, M Hadani
Journal of Endocrinological Investigation|June 9, 2007
Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axisY Toledano, A Lubetsky, I Shimon
Pituitary|June 1, 2001
Hypopituitarism following closed head injuryG Segal-Lieberman, A Karasik, I Shimon
Pituitary|December 28, 2002
Pituitary macroadenoma secreting thyrotropin and growth hormone: remission of bihormonal hypersecretion in response to lanreotide therapyI Shimon, D Nass, D J Gross
Pituitary|May 11, 2011
Acute cortisol release during stereotactic fractionated radiotherapy to an ACTH-secreting pituitary macroadenomaI Shimon, Y Manisterski, A A Kanner
Journal of Endocrinological Investigation|January 8, 2005
PTR-3173 (somatoprim), a novel somatostatin analog with affinity for somatostatin receptors 2, 4 and 5 is a potent inhibitor of human GH secretionI Shimon, T Rubinek, M Hadani, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Pituitary|November 18, 2000
Acromegaly with normal growth hormone levels: response to Sandostatin-LAR treatmentI Shimon, D Nass, M Hadani
Clinical Endocrinology|November 1, 1995
Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literatureI Shimon, A Kneller, D Olchovsky
Hormone Research|January 1, 1995
Home monitoring of 17 alpha-hydroxyprogesterone levels by filter paper blood spots in patients with 21-hydroxylase deficiencyI Shimon, I Kaiserman, J Sack
The Journal of Clinical Endocrinology and Metabolism|January 22, 1998
Human fetal pituitary expresses functional growth hormone-releasing peptide receptorsI Shimon, X Yan, S Melmed
Journal of Endocrinological Investigation|June 1, 1995
Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma)M Berezin, I Shimon, M Hadani
Journal of Endocrinological Investigation|June 9, 2007
Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axisY Toledano, A Lubetsky, I Shimon
Pituitary|June 1, 2001
Hypopituitarism following closed head injuryG Segal-Lieberman, A Karasik, I Shimon
Pituitary|December 28, 2002
Pituitary macroadenoma secreting thyrotropin and growth hormone: remission of bihormonal hypersecretion in response to lanreotide therapyI Shimon, D Nass, D J Gross
Pituitary|May 11, 2011
Acute cortisol release during stereotactic fractionated radiotherapy to an ACTH-secreting pituitary macroadenomaI Shimon, Y Manisterski, A A Kanner
Journal of Endocrinological Investigation|January 8, 2005
PTR-3173 (somatoprim), a novel somatostatin analog with affinity for somatostatin receptors 2, 4 and 5 is a potent inhibitor of human GH secretionI Shimon, T Rubinek, M Hadani, et al.
Pageof 6